Stada Recruits Ex-Sandoz Exec To Help Steer Biosimilars

Christine Berndt Previously Headed Biosimilar Development Programs At Sandoz

 
• By David Wallace
  
Wooden blocks leader selected chosen people put forward
Christine Berndt will be head of global development for specialty/biosimilar drugs at Stada • Source: Paradee Kietsirikul / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Leadership

More from Generics Bulletin